Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-10-17
2006-10-17
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S331000, C544S324000, C514S275000
Reexamination Certificate
active
07122670
ABSTRACT:
The present invention relates to a method of making a compound of the formulawherein X1, X2and R3—R4are as defined herein. The method includes reacting a compound of the formulawith an amine of formula 3 (HNR3R4) in the presence of a Lewis Acid and a non-nucleophilic base. The 2,4-diamino pyrimidine moiety is a common component in a variety of biologically active drug-like molecules and pyrimidine derivatives have been found to be useful in the treatment of abnormal cell growth, such as cancer, in mammals.
REFERENCES:
patent: 03030909 (2003-04-01), None
Diringer et al., Journal of Medicinal Chemistry, vol. 13, No. 1, pp. 151-152 (1970).
Kath John Charles
Luzzio Michael Joseph
Richter Daniel Tyler
Balasubramanian Venkataraman
Kershner David L.
Pfizer Inc
Zelson Steven
LandOfFree
Selective synthesis of CF3-substituted pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective synthesis of CF3-substituted pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective synthesis of CF3-substituted pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714204